Loading...
XSHE002462
Market cap475mUSD
Jan 10, Last price  
11.94CNY
1D
-2.93%
1Q
-1.57%
IPO
-22.87%
Name

Cachet Pharmaceutical Co Ltd

Chart & Performance

D1W1MN
XSHE:002462 chart
P/E
13.93
P/S
0.12
EPS
0.86
Div Yield, %
6.15%
Shrs. gr., 5y
3.06%
Rev. gr., 5y
10.80%
Revenues
30.00b
+14.40%
662,903,001965,221,7981,133,559,8451,341,671,1341,801,380,2392,554,073,3033,544,275,1675,572,152,3398,199,831,90810,971,576,55714,238,899,71617,959,885,46622,186,572,87423,256,135,89125,625,618,76926,219,790,24429,996,240,361
Net income
250m
-46.60%
182,625,34341,356,80742,418,31248,542,36963,682,54965,209,640130,168,774228,060,085172,976,469223,099,559263,641,638327,633,235659,802,381590,903,501601,878,580468,312,507250,060,041
CFO
1.60b
054,833,05150,116,113-49,607,20848,574,6100000116,304,01300293,114,5561,114,869,517913,127,42301,595,439,529
Dividend
Jun 27, 20240.26 CNY/sh
Earnings
May 21, 2025

Profile

Cachet Pharmaceutical Co., Ltd. engages in the wholesale and retail sale of pharmaceutical products in China. It is involved in the supply of medicines to hospitals; wholesale of biological products, medical instruments, and traditional Chinese medicines; pharmaceutical logistic operations; and manufacture of medicines. The company owns 150 chain stores in Beijing that sell medicines, health care foods, medical instruments, cosmetics, daily necessities, and traditional Chinese medicines. Cachet Pharmaceutical Co., Ltd. was founded in 1998 and is based in Beijing, China.
URL
http://www.cachet.com.cn/
IPO date
Aug 18, 2010
Employees
Domiciled in
CN
Incorporated in
CN

Valuation

Title
CNY in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFY
2023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
29,996,240
14.40%
26,219,790
2.32%
Cost of revenue
28,490,676
25,010,611
Unusual Expense (Income)
NOPBT
1,505,564
1,209,180
NOPBT Margin
5.02%
4.61%
Operating Taxes
178,748
176,594
Tax Rate
11.87%
14.60%
NOPAT
1,326,816
1,032,586
Net income
250,060
-46.60%
468,313
-22.19%
Dividends
(214,345)
(107,932)
Dividend yield
5.19%
2.57%
Proceeds from repurchase of equity
BB yield
Debt
Debt current
3,787,854
4,067,996
Long-term debt
351,891
417,516
Deferred revenue
Other long-term liabilities
1
Net debt
1,252,401
2,299,509
Cash flow
Cash from operating activities
1,595,440
CAPEX
(199,295)
Cash from investing activities
Cash from financing activities
(631,492)
FCF
2,048,665
381,728
Balance
Cash
2,885,601
2,183,724
Long term investments
1,743
2,279
Excess cash
1,387,532
875,014
Stockholders' equity
4,573,290
4,643,405
Invested Capital
8,667,780
9,226,582
ROIC
14.83%
11.65%
ROCE
14.97%
11.96%
EV
Common stock shares outstanding
290,767
291,707
Price
14.21
-1.25%
14.39
2.27%
Market cap
4,131,806
-1.57%
4,197,665
2.27%
EV
7,235,195
8,340,755
EBITDA
1,786,531
1,435,929
EV/EBITDA
4.05
5.81
Interest
155,416
175,307
Interest/NOPBT
10.32%
14.50%